QuickView for oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (biogroup)

1. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
2. Chronically inflammed, cirrhotic and cancerous liver expression profiles
3. L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens
4. L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
5. L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens

There were no matches for oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen

There were no clinical trials for oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen